CN101564431A - 一种强身抗疲劳抗衰老的中药制剂及其制作方法 - Google Patents
一种强身抗疲劳抗衰老的中药制剂及其制作方法 Download PDFInfo
- Publication number
- CN101564431A CN101564431A CNA2009101478221A CN200910147822A CN101564431A CN 101564431 A CN101564431 A CN 101564431A CN A2009101478221 A CNA2009101478221 A CN A2009101478221A CN 200910147822 A CN200910147822 A CN 200910147822A CN 101564431 A CN101564431 A CN 101564431A
- Authority
- CN
- China
- Prior art keywords
- time
- temperature
- water
- polygoni multiflori
- portions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 238000000034 method Methods 0.000 title claims abstract description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 27
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 26
- 239000007788 liquid Substances 0.000 claims abstract description 17
- 239000000463 material Substances 0.000 claims abstract description 11
- 238000001035 drying Methods 0.000 claims abstract description 10
- 239000008187 granular material Substances 0.000 claims abstract description 5
- 241000222336 Ganoderma Species 0.000 claims description 22
- 241001251068 Formica fusca Species 0.000 claims description 20
- 239000000284 extract Substances 0.000 claims description 14
- 238000000605 extraction Methods 0.000 claims description 10
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 7
- 238000001914 filtration Methods 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 5
- 230000009471 action Effects 0.000 claims description 3
- 239000012535 impurity Substances 0.000 claims description 3
- 238000003809 water extraction Methods 0.000 claims description 3
- 239000012567 medical material Substances 0.000 claims description 2
- 238000007873 sieving Methods 0.000 claims description 2
- 230000036541 health Effects 0.000 abstract description 9
- 235000013305 food Nutrition 0.000 abstract description 7
- 240000008397 Ganoderma lucidum Species 0.000 abstract 3
- 235000001637 Ganoderma lucidum Nutrition 0.000 abstract 3
- 241000233866 Fungi Species 0.000 abstract 2
- 241000257303 Hymenoptera Species 0.000 abstract 2
- 240000001307 Myosotis scorpioides Species 0.000 abstract 2
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 2
- 240000001341 Reynoutria japonica Species 0.000 abstract 2
- 239000006286 aqueous extract Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 28
- 210000003734 kidney Anatomy 0.000 description 14
- 210000004185 liver Anatomy 0.000 description 14
- 241000190633 Cordyceps Species 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 230000007812 deficiency Effects 0.000 description 8
- 201000004384 Alopecia Diseases 0.000 description 7
- 231100000360 alopecia Toxicity 0.000 description 7
- 230000036737 immune function Effects 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 230000003712 anti-aging effect Effects 0.000 description 6
- 230000000975 bioactive effect Effects 0.000 description 6
- 230000003203 everyday effect Effects 0.000 description 6
- 206010016256 fatigue Diseases 0.000 description 6
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 5
- 230000001815 facial effect Effects 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 206010022437 insomnia Diseases 0.000 description 5
- 230000037303 wrinkles Effects 0.000 description 5
- 206010003549 asthenia Diseases 0.000 description 4
- 208000029078 coronary artery disease Diseases 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 206010029446 nocturia Diseases 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 3
- 230000000259 anti-tumor effect Effects 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 235000008504 concentrate Nutrition 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 201000001881 impotence Diseases 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 230000035900 sweating Effects 0.000 description 3
- 208000037259 Amyloid Plaque Diseases 0.000 description 2
- 206010006895 Cachexia Diseases 0.000 description 2
- 241000005787 Cistanche Species 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 206010058314 Dysplasia Diseases 0.000 description 2
- 208000036119 Frailty Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 208000002454 Nasopharyngeal Carcinoma Diseases 0.000 description 2
- 206010061306 Nasopharyngeal cancer Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 208000007443 Neurasthenia Diseases 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 230000003288 anthiarrhythmic effect Effects 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 208000013116 chronic cough Diseases 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- OFEZSBMBBKLLBJ-BAJZRUMYSA-N cordycepin Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)C[C@H]1O OFEZSBMBBKLLBJ-BAJZRUMYSA-N 0.000 description 2
- OFEZSBMBBKLLBJ-UHFFFAOYSA-N cordycepine Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)CC1O OFEZSBMBBKLLBJ-UHFFFAOYSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000026500 emaciation Diseases 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000037308 hair color Effects 0.000 description 2
- 230000003779 hair growth Effects 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 201000011216 nasopharynx carcinoma Diseases 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 206010036596 premature ejaculation Diseases 0.000 description 2
- AQHHHDLHHXJYJD-UHFFFAOYSA-N propranolol Chemical compound C1=CC=C2C(OCC(O)CNC(C)C)=CC=CC2=C1 AQHHHDLHHXJYJD-UHFFFAOYSA-N 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 230000033764 rhythmic process Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 208000008203 tachypnea Diseases 0.000 description 2
- 206010043089 tachypnoea Diseases 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 229940124549 vasodilator Drugs 0.000 description 2
- 239000003071 vasodilator agent Substances 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 206010006582 Bundle branch block right Diseases 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- KQLDDLUWUFBQHP-UHFFFAOYSA-N Cordycepin Natural products C1=NC=2C(N)=NC=NC=2N1C1OCC(CO)C1O KQLDDLUWUFBQHP-UHFFFAOYSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 208000002249 Diabetes Complications Diseases 0.000 description 1
- 206010012655 Diabetic complications Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000019395 Lactation disease Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 208000019914 Mental Fatigue Diseases 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 241001248610 Ophiocordyceps sinensis Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010039085 Rhinitis allergic Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 206010042576 Suppressed lactation Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 201000010105 allergic rhinitis Diseases 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000003560 cancer drug Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 210000002816 gill Anatomy 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 229940126904 hypoglycaemic agent Drugs 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000001983 lactogenic effect Effects 0.000 description 1
- 235000014666 liquid concentrate Nutrition 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000012946 outsourcing Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000004793 poor memory Effects 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 229960003712 propranolol Drugs 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
成分 | 天然虫草含量 | 金虫草(益元虫草)含量 | 作用/功效 |
虫草素(3’-脱氧腺苷) | 0.08mg/g | 12mg/g | 抗肿瘤、滋肺补肾、治疗久咳、支气管发炎、夜尿频多。 |
虫草酸(甘露醇) | 86mg/g | 44mg/g | 软化、疏通心脑血管、修复肾功能、抗菌消炎。 |
虫草多糖 | 5% | 8.6% | 提高免疫功能;保肺护肝,增加乙肝病人(HBsAg)转阴率和改善调整心律,降血压、舒张血管、抗心率失常。 |
腺苷 | 0.07% | 0.085% | 调整心率、降血压、舒张血管、抗心率失常。 |
SOD(超氧化物歧化酶) | 183ug/mg(pro) | 986ug/mg(pro) | 抗氧化、防衰老、防色素沉着、养颜、延缓更年期。 |
氨基酸(18种) | 2340(mg/100g) | 11145(mg/100g) | 平衡人体机能、辅助治疗消化系统和神经系统疾病。 |
多种微量元素(硒、锗|、钾、磷、镁、钼、锰、铜、钙) | 15813(ug/g) | 23985(ug/g) | 调节人体生理机能、治疗性功能低下、不育。 |
多种维生素(A、B1、B2、B6、B12、C、D3、E、PP等) | 0..24mg/g | 9.2mg/g | 调节人体生理功能、治疗厌食失眠等、增强抗病能力。 |
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009101478221A CN101564431B (zh) | 2009-06-15 | 2009-06-15 | 一种强身抗疲劳抗衰老的中药制剂及其制作方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009101478221A CN101564431B (zh) | 2009-06-15 | 2009-06-15 | 一种强身抗疲劳抗衰老的中药制剂及其制作方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101564431A true CN101564431A (zh) | 2009-10-28 |
CN101564431B CN101564431B (zh) | 2011-08-17 |
Family
ID=41280908
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009101478221A Expired - Fee Related CN101564431B (zh) | 2009-06-15 | 2009-06-15 | 一种强身抗疲劳抗衰老的中药制剂及其制作方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101564431B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103191197B (zh) * | 2012-01-05 | 2015-09-30 | 何忠琳 | 靶向式抗肿瘤抗癌药剂及其制备方法 |
CN105998753A (zh) * | 2016-07-13 | 2016-10-12 | 卢祥平 | 一种治疗糖尿病、高血压、四肢无力、皮肤病的药物 |
CN108992472A (zh) * | 2018-09-11 | 2018-12-14 | 高策 | 具有补肾保健延寿功效的保健口服剂及其制备工艺 |
-
2009
- 2009-06-15 CN CN2009101478221A patent/CN101564431B/zh not_active Expired - Fee Related
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103191197B (zh) * | 2012-01-05 | 2015-09-30 | 何忠琳 | 靶向式抗肿瘤抗癌药剂及其制备方法 |
CN105998753A (zh) * | 2016-07-13 | 2016-10-12 | 卢祥平 | 一种治疗糖尿病、高血压、四肢无力、皮肤病的药物 |
CN108992472A (zh) * | 2018-09-11 | 2018-12-14 | 高策 | 具有补肾保健延寿功效的保健口服剂及其制备工艺 |
Also Published As
Publication number | Publication date |
---|---|
CN101564431B (zh) | 2011-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103719498B (zh) | 一种提高免疫力的黄精保健茶及其制备方法 | |
CN101904387B (zh) | 一种补肾壮阳男人八宝茶 | |
CN102640829B (zh) | 具有改善心肌缺血功能的茶膏及其制备方法 | |
CN1757317A (zh) | 罗汉果片及其制备工艺 | |
CN103859378A (zh) | 一种有助于降低血糖的养生保健食品配方及其制备方法 | |
CN101612315A (zh) | 一种用于调整人体机能的中药复方制剂 | |
CN106806643A (zh) | 一种治疗糖尿病的中药组合物 | |
CN107319086A (zh) | 一种枸杞金丝皇菊压片糖果及其制备方法 | |
CN105166235A (zh) | 一种气血双补降三高的保健茶及其制备方法 | |
CN101549101B (zh) | 一种用于治疗尘肺病和耐药性肺结核病的中药及制备方法 | |
CN105079465A (zh) | 一种降低血糖的组合物 | |
CN103859375A (zh) | 一种有助于增强免疫力的养生保健食品配方及其制备方法 | |
CN106266631A (zh) | 一种含有葛根的组合物及其提取装置和方法 | |
CN103099833A (zh) | 有助于缓解运动疲劳和延缓衰老的软胶囊及其制备方法 | |
CN107034118A (zh) | 一种静心安神营养醋及其制作工艺 | |
CN109395028A (zh) | 一种预防、治疗三高症的葛景甲参酒配方及制备方法 | |
CN101564431B (zh) | 一种强身抗疲劳抗衰老的中药制剂及其制作方法 | |
CN101549046B (zh) | 北冬虫夏草和灵芝的养生保健品 | |
CN103463625B (zh) | 养心补血营养制剂 | |
CN102715509B (zh) | 一种排毒养颜保健品 | |
CN110812419A (zh) | 一种固肾强腰的黑参丸和制备方法 | |
CN106072656A (zh) | 一种无添加剂预防及缓解痛经的健康食品及其生产方法 | |
CN102125128A (zh) | 一种九味降糖茶 | |
CN107712890A (zh) | 一种宁心安神膏滋及其制备方法 | |
CN104225425A (zh) | 一种提高免疫力、改善睡眠、预防心脑血管疾病的中药制剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
DD01 | Delivery of document by public notice |
Addressee: Wu Junjie Document name: Notification of Publication of the Application for Invention |
|
DD01 | Delivery of document by public notice |
Addressee: Wu Junjie Document name: Notification to Go Through Formalities of Registration |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20151223 Address after: 510000 Tianhe District, Guangdong, Tianhe Road, No. 3801, room 230, the self compiled unit 06, Patentee after: GUANGZHOU FENGZHI BIO-TECHNOLOGY CO., LTD. Address before: 510163 Guangdong city of Guangzhou province Liwan District Island Garden 24 building 1308 room Patentee before: Wu Junjie |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110817 Termination date: 20170615 |
|
CF01 | Termination of patent right due to non-payment of annual fee |